Fidelity Investments’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $122K | Sell |
|
|||||
|
2023
Q4 | $120K | Sell |
|
|||||
|
2023
Q3 | $115K | Buy |
|
|||||
|
2023
Q2 | $4.13K | Buy |
|
|||||
|
2023
Q1 | $2.09K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $0 | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $0 | Hold |
|
|||||
|
2020
Q3 | $0 | Hold |
|
|||||
|
2020
Q2 | $0 | Sell |
|
|||||
|
2020
Q1 | $0 | Hold |
|
|||||
|
2019
Q4 | $0 | Sell |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $0 | Sell |
|
|||||
|
2019
Q1 | $1K | Sell |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $4K | Sell |
|
|||||
|
2018
Q2 | $241K | Sell |
|
|||||
|
2018
Q1 | $13M | Buy |
|
|||||
|
2017
Q4 | $16.4M | Buy |
|
|||||
|
2017
Q3 | $23M | Sell |
|
|||||
|
2017
Q2 | $21.4M | Sell |
|
|||||
|
2017
Q1 | $59.5M | Sell |
|
|||||
|
2016
Q4 | $79.3M | Buy |
|
|||||
|
2016
Q3 | $123M | Buy |
|
|||||
|
2016
Q2 | $103M | Buy |
|
|||||
|
2016
Q1 | $146M | Buy |
|
|||||
|
2015
Q4 | $137M | Buy |
|
|||||
|
2015
Q3 | $142M | Buy |
|
|||||
|
2015
Q2 | $204M | Buy |
|
|||||
|
2015
Q1 | $192M | Buy |
|
|||||
|
2014
Q4 | $179M | Buy |
|
|||||
|
2014
Q3 | $138M | Buy |
|
|||||
|
2014
Q2 | $113M | Buy |
|
|||||
|
2014
Q1 | $78.1M | Buy |
|
|||||
|
2013
Q4 | $82M | Sell |
|
|||||
|
2013
Q3 | $59.3M | Sell |
|
|||||
|
2013
Q2 | $107M | Buy |
|